Yourgene Health Launches Insight DPYD Assay. Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients
Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces the launch of LightBench® Discover, a high-precision 3-in-1 instrument for genomic research labs conducting long-read sequencing.
IVDR accreditation achieved for Yourgene® QST*R Base assay for Rapid Aneuploidy Analysis.
Offers expectant parents fully comprehensive prenatal screening test for genetic conditions, including microdeletions.
IVDR certification achieved for Cystic Fibrosis Base reproductive assay.
IVDR certification achieved for DPYD genotyping assay. First product of its kind to conform with new IVDR requirements. Yourgene Health (part of the Novacyt group), an international specialist in clinical diagnostics, confirms – IVDR accreditation under the new requirements of the In Vitro Diagnostic Regulation (“IVDR”) for its DPYD genotyping assay, which helps identify cancer patients at risk of suffering a severe, and potentially life-threatening, reaction to common chemotherapy.
Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries Yourgene’s LightBench instrument offers precise and accurate target enrichment of PacBio HiFi SMRTbell sequencing libraries increasing HiFi sequencing yields Manchester, UK, 16 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, and PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration to optimise size selection for long-read sequencing workflows. PacBio has qualified Yourgene’s LightBench® instrument for the size selection of long DNA fragments, enabling high yields for HiFi sequencing data.
Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents Manchester, UK, and Rabat, MOROCCO, 09 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, has installed the first non-invasive prenatal testing (NIPT) workflow in Morocco based on the IONA® test at the Centre de Biologie Riad (Laboriad). By offering this service locally, Laboriad can broaden its offering and provide pregnant women fast, reliable results that reduce the need for invasive tests and the associated stress and anxiety for expectant parents.
IVDR certification achieved for DPYD genotyping assay First product of its kind to conform with new IVDR requirements Yourgene Health (part of the Novacyt group), an international specialist in clinical diagnostics, confirms – IVDR accreditation under the new requirements of the In Vitro Diagnostic Regulation (“IVDR”) for its DPYD genotyping assay, which helps identify cancer patients at risk of suffering a severe, and potentially life-threatening, reaction to common chemotherapy.
Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow Manchester, UK, and SINGAPORE, 5 September 2023: Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, today launched the Yourgene® MagBench™ Automated DNA Extraction Instrument and Kit.